Guided by a long-term retrospective observa-bone lesions (n ฯญ 27), which remained asymption, the clinical course and treatment of Langer-tomatic or showed a remission to treatment, hans'-cell histiocytosis (LCH) in adult patients multifocal LCH had a more aggressive course. are represented. The seri
Ear involvement in childhood Langerhans' cell histiocytosis
โ Scribed by Giammarco Surico; Paola Muggeo; Vito Muggeo; Valeria Conti; Chiara Novielli; Annarosa Romano; Giuseppe Loiacono; Adriana Ceci; Nicola Rigillo
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 74 KB
- Volume
- 22
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
โฆ Synopsis
Background. Ear involvement (EI) in Langerhans' cell histiocytosis (LCH) occurs quite often. We reviewed the Italian pediatric population of 251 children with LCH diagnosed between 1982 and 1995, focusing on EI, to highlight the prevalence, the clinical presentation, the outcome during follow-up, and the prognostic impact of otologic LCH.
Methods. EI was defined by chronic otorrhea and/or mastoid infiltration, external auditory meatus lesions, and middle/internal EI. The age at diagnosis, sex, system involved, organ dysfunction, treatment, disease control, and outcome were recorded.
Results. EI was noted at presentation in 34 children (13.5%). They had a younger age at diagnosis (p = .0013) and near totality of multisystem disease (93.8% of patients with EI). Among patients with multisystem disease, children with EI seemed to have a higher risk of poor response and a higher percentage of second line treatment (p = .003).
Conclusions. EI seems to identify patients with a particular disease behavior, which requires a more accurate evaluation at diagnosis, staging and treatment, and a strict follow-up, considering the possibility of an unfavorable outcome.
๐ SIMILAR VOLUMES
Background. Because prostaglandin (PG) E2 has been identified in the bone lesions of Langerhans cell histiocytosis (LCH), we speculated that indomethacin, a potent PG inhibitor, may be useful in patients with symptomatic LCH involving the bony skeleton. Procedure. We used indomethacin to treat patie
The etiology of Langerhans cell histiocytosis (LCH) is unknown. Viral causes, including human herpesvirus type 6 (HHV6), have been suggested but remain unproved. The recently discovered human herpesvirus type 8 (HHV8), the cause of Kaposi's sarcoma, infects dendritic cells in the bone marrow associa
Background. Manifestations of Langerhans cell histiocytosis (LCH) in children range from only a rash, to bony lesions accompanied by pain, to major organ disease. When the central nervous system (CNS) is affected, the LCH patient may exhibit signs and symptoms of hypothalamic and pituitary dysfuncti